Black Rock Inc. Allakos Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Allakos Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,720,771 shares of ALLK stock, worth $5.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,720,771

Previous 5,116,088 7.73%

Holding current value

$5.9 Million

Previous $14 Million 57.41%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.02 - $3.23 $403,223 - $1.28 Million	-395,317 Reduced 7.73%	4,720,771 $5.95 Million
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.18 $1.07 Million - $1.97 Million	-619,360 Reduced 10.8%	5,116,088 $14 Million
Q3 2023 Nov 13, 2023	SELL	$2.13 - $5.55 $520,493 - $1.36 Million	-244,363 Reduced 4.09%	5,735,448 $13 Million
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $12.3 Million - $18 Million	3,428,359 Added 134.37%	5,979,811 $26.1 Million
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $553,547 - $1.06 Million	128,732 Added 5.31%	2,551,452 $11.4 Million

Q4 2022 Feb 13, 2023	BUY	$5.97 - $8.42 $1.55 Million - $2.19 Million	260,082 Added 12.03%	2,422,720 $20.4 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $5.84 $1.65 Million - $3.19 Million	545,508 Added 33.73%	2,162,638 $13.2 Million
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $3.37 Million - $7.95 Million	-1,294,769 Reduced 44.46%	1,617,130 $5.06 Million
Q1 2022 May 12, 2022	BUY	$5.08 - $9.81 $1.15 Million - $2.22 Million	226,498 Added 8.43%	2,911,899 $16.6 Million
Q4 2021 Feb 10, 2022	SELL	$8.55 - $111.89 $1.26 Million - $16.5 Million	-147,883 Reduced 5.22%	2,685,401 $26.3 Million
Q3 2021 Nov 09, 2021	SELL	$76.53 - $110.43 $53 Million - $76.5 Million	-692,570 Reduced 19.64%	2,833,284 $300 Million
Q2 2021 Aug 11, 2021	BUY	$85.37 - $114.1 $301 Million - $402 Million	3,525,854 New	3,525,854 $301 Million

Others Institutions Holding ALLK

# of Institutions

103

Shares Held

77.4M

Call Options Held

70.7K

Put Options Held

2.8K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $106M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account